Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Abbott and Insulet Partner to Integrate Next-Generation Glucose Sensing and Automated Insulin Delivery Technologies for Seamless Diabetes Care
- Collaboration will combine Abbott's leading continuous glucose monitoring (CGM) technology with Insulet's Omnipod Horizon™ Automated Insulin Delivery System to offer an accurate, easy-to-use, integrated digital health platform - Integrated technology will provide people living with diabetes
View HTML
Toggle Summary Beyond Type 1's CrossCountry "Bike Beyond" Program To Kick Off On June 3rd, 2017
Toggle Summary Christopher Gorham Grabs Silver and Bronze Medals at International Karate/Kickboxing Championships
The OmniPod(R) Insulin Management System Helps Young Athletes With Diabetes Win Top Medals in Their Sports
View HTML
Toggle Summary Daniel Levangie Appointed to Insulet's Board of Directors
Healthcare Industry Expert to Bring Sales and Marketing Experience to Insulet Board
View HTML
Toggle Summary Dexcom and Insulet Announce Commercial Agreement to Integrate the Dexcom G6 and Future G7 CGM into Insulet’s Omnipod Horizon™ Automated Insulin Delivery System
First-ever automated insulin delivery with the tubeless Omnipod Insulin Management System and personal smartphone control Initially compatible with Dexcom G6 CGM, with no fingersticks* required Integration with the next generation Dexcom G7 CGM system, once available SAN DIEGO & ACTON, Mass.
View HTML
Toggle Summary Elite Skier Uses OmniPod(R) Insulin Management System at World Championships
Kris Freeman Joins Growing Ranks of Professional Athletes Who Use the OmniPod System to Manage their Diabetes
View HTML
Toggle Summary Fiasp® Rapid Acting Insulin for Adults Now Approved for Use With the Omnipod Insulin Management System Platform in the United States
Insulet Further Demonstrating Commitment to Innovation and Patient Choice ACTON, Mass. --(BUSINESS WIRE)--Oct. 25, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today
View HTML
Toggle Summary First Patients in Europe Start Using Insulet’s New Omnipod DASH™ Insulin Management System in the UK and the Netherlands
LONDON --(BUSINESS WIRE)--Dec. 18, 2019-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced the launch of the new Omnipod DASH™ Insulin Management System
View HTML
Toggle Summary Insulet Achieves Key Milestones to Support its Transition to Direct Operations in Europe on July 1, 2018
High-Caliber Team in Place Throughout Key Geographies Partnerships Established with Experienced European Companies for Customer Care and Logistics BILLERICA, Mass. & LONDON --(BUSINESS WIRE)--May 3, 2018-- Insulet Corporation (NASDAQ:PODD) ( Insulet or the Company), the leader in tubeless insulin
View HTML
Toggle Summary Insulet Amends Deerfield Credit Facility and Issues Stock
More Than $12 Million in Savings Expected Over Next Three Years
View HTML